A Dark Vector Cognition product

Item 1. Financial Statements

128K characters. Original on sec.gov ·

Item 1. Financial Statements

The 65 tables in Item 1. Financial Statements as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

Table of Contents

Consolidated Condensed Statements of Operations
Three Months Ended
(In Millions, Except Per Share Amounts; Unaudited)Mar 29, 2025Mar 30, 2024
Net revenue$12,667$12,724
Cost of sales7,9957,507
Gross margin4,6725,217
Research and development3,6404,382
Marketing, general, and administrative1,1771,556
Restructuring and other charges156348
Operating expenses4,9736,286
Operating income (loss)(301)(1,069)
Gains (losses) on equity investments, net(112)205
Interest and other, net(173)145
Income (loss) before taxes(586)(719)
Provision for (benefit from) taxes301(282)
Net income (loss)(887)(437)
Less: net income (loss) attributable to non-controlling interests(66)(56)
Net income (loss) attributable to Intel$(821)$(381)
Earnings (loss) per share attributable to Intel—basic$(0.19)$(0.09)
Earnings (loss) per share attributable to Intel—diluted$(0.19)$(0.09)
Weighted average shares of common stock outstanding:
Basic4,3434,242
Diluted4,3434,242

See accompanying notes.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsConsolidated Condensed Statements of Income3

Table of Contents

Consolidated Condensed Statements of Comprehensive Income (Loss)
Three Months Ended
(In Millions; Unaudited)Mar 29, 2025Mar 30, 2024
Net income (loss)$(887)$(437)
Changes in other comprehensive income (loss), net of tax:
Net unrealized holding gains (losses) on derivatives225(328)
Actuarial valuation and other pension benefits (expenses), net1—
Translation adjustments and other(1)1
Other comprehensive income (loss)225(327)
Total comprehensive income (loss)(662)(764)
Less: comprehensive income (loss) attributable to non-controlling interests(66)(56)
Total comprehensive income (loss) attributable to Intel$(596)$(708)

See accompanying notes.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsConsolidated Condensed Statements of Comprehensive Income4

Table of Contents

Consolidated Condensed Balance Sheets
(In Millions; Unaudited)Mar 29, 2025Dec 28, 2024
Assets
Current assets:
Cash and cash equivalents$8,947$8,249
Short-term investments12,10113,813
Accounts receivable, net3,0643,478
Inventories12,28112,198
Other current assets5,7419,586
Total current assets42,13447,324
Property, plant, and equipment, net of accumulated depreciation of $103,036 ($102,193 as of December 28, 2024)109,763107,919
Equity investments5,0275,383
Goodwill24,69324,693
Identified intangible assets, net3,5683,691
Other long-term assets7,0577,475
Total assets$192,242$196,485
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$10,896$12,556
Accrued compensation and benefits2,6523,343
Short-term debt5,2403,729
Income taxes payable1,8731,756
Other accrued liabilities11,51314,282
Total current liabilities32,17435,666
Debt44,91146,282
Other long-term liabilities8,7449,505
Contingencies (Note 13)
Stockholders’ equity:
Common stock and capital in excess of par value, 4,362 issued and outstanding (4,330 issued and outstanding as of December 28, 2024)51,92050,949
Accumulated other comprehensive income (loss)(486)(711)
Retained earnings48,32249,032
Total Intel stockholders' equity99,75699,270
Non-controlling interests6,6575,762
Total stockholders' equity106,413105,032
Total liabilities and stockholders’ equity$192,242$196,485

See accompanying notes.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsConsolidated Condensed Balance Sheets5

Table of Contents

Consolidated Condensed Statements of Cash Flows
Three Months Ended
(In Millions; Unaudited)Mar 29, 2025Mar 30, 2024
Cash and cash equivalents, beginning of period$8,249$7,079
Cash flows provided by (used for) operating activities:
Net income (loss)(887)(437)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation2,4252,200
Share-based compensation6841,179
Amortization of intangibles249351
(Gains) losses on equity investments, net112(208)
Deferred taxes19(346)
Changes in assets and liabilities:
Accounts receivable41480
Inventories(83)(366)
Accounts payable(240)(386)
Accrued compensation and benefits(741)(1,160)
Income taxes67(245)
Other assets and liabilities(1,206)(1,885)
Total adjustments1,700(786)
Net cash provided by (used for) operating activities813(1,223)
Cash flows provided by (used for) investing activities:
Additions to property, plant, and equipment(5,183)(5,970)
Proceeds from capital-related government incentives803592
Purchases of short-term investments(3,386)(6,460)
Maturities and sales of short-term investments5,3279,598
Proceeds from divestitures1,935—
Other investing585(323)
Net cash provided by (used for) investing activities81(2,563)
Cash flows provided by (used for) financing activities:
Issuance of commercial paper, net of issuance costs1,496793
Partner contributions955423
Additions to property, plant, and equipment(1,020)—
Issuance of long-term debt, net of issuance costs—2,537
Repayment of debt(1,500)—
Proceeds from sales of common stock through employee equity incentive plans491626
Payment of dividends to stockholders—(529)
Other financing(618)(220)
Net cash provided by (used for) financing activities(196)3,630
Net increase (decrease) in cash and cash equivalents698(156)
Cash and cash equivalents, end of period$8,947$6,923
Non-cash supplemental disclosures:
Acquisition of property, plant, and equipment1$3,932$5,167
Recognition of capital-related government incentives$985$535
Cash paid during the period for:
Interest, net of capitalized interest$635$540
Income taxes, net of refunds$221$315

*1.*Includes $451 million with extended payment terms of greater than 90 days in the three months ended March 29, 2025.

See accompanying notes.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsConsolidated Condensed Statements of Cash Flows6

Table of Contents

Consolidated Condensed Statements of Stockholders' Equity
(In Millions, Except Per Share Amounts; Unaudited)Common Stock and Capital in Excess of Par ValueAccumulated Other Comprehensive Income (Loss)Retained Earnings****1Non-Controlling InterestsTotal
SharesAmount
Three Months Ended
Balance as of December 28, 20244,330$50,949$(711)$49,081$5,762$105,081
Net income (loss)———(821)(66)(887)
Other comprehensive income (loss)——225——225
Net proceeds from partner contributions—(2)——957955
Partner distributions————(58)(58)
Employee equity incentive plans and other36491———491
Share-based compensation—622——62684
Restricted stock unit withholdings(4)(140)—62—(78)
Balance as of March 29, 20254,362$51,920$(486)$48,322$6,657$106,413
Balance as of December 30, 20234,228$36,649$(215)$69,156$4,375$109,965
Net income (loss)———(381)(56)(437)
Other comprehensive income (loss)——(327)——(327)
Net proceeds from partner contributions————423423
Employee equity incentive plans and other32626———626
Share-based compensation—1,138——411,179
Restricted stock unit withholdings(3)(122)—(22)—(144)
Cash dividends declared ($0.13 per share of common stock)———(529)—(529)
Balance as of March 30, 20244,257$38,291$(542)$68,224$4,783$110,756

*1.*The retained earnings balance as of December 28, 2024 includes an opening balance adjustment made as a result of the adoption of a new accounting standard in 2025.

See accompanying notes.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsConsolidated Condensed Statements of Stockholders' Equity7

Table of Contents

Notes to Consolidated Condensed Financial Statements
Note 1 :Basis of Presentation

We prepared our interim Consolidated Condensed Financial Statements that accompany these notes in conformity with US GAAP, consistent in all material respects with those applied in our 2024 Form 10-K.

We have made estimates and judgments affecting the amounts reported in our Consolidated Condensed Financial Statements and the accompanying notes. The actual results that we experience may differ materially from our estimates. The interim financial information is unaudited, and reflects all normal adjustments that are, in our opinion, necessary to provide a fair statement of results for the interim periods presented. This report should be read in conjunction with our 2024 Form 10-K where we include additional information on our critical accounting estimates, policies, and the methods and assumptions used in our estimates.

We made certain reclassifications within our Consolidated Condensed Financial Statements, and, in certain cases, adjusted prior periods to conform to the current period presentation. These reclassifications had no impact on previously reported net income (loss), cash flows, or stockholders' equity.

Note 2 :Operating Segments

In the first quarter of 2025, we made an organizational change to integrate NEX into CCG and DCAI and modified our segment reporting to align to this and certain other business reorganizations. All prior period segment data has been retrospectively adjusted to reflect the way our CODM internally receives information and manages and monitors our operating segment performance starting in fiscal year 2025. There are no changes to our consolidated financial statements for any prior periods.

We manage our business through the following operating segments:

**▪**Intel Products:

**▪**Client Computing Group (CCG)

**▪**Data Center and AI (DCAI)

**▪**Intel Foundry

**▪**All Other

**▪**Altera

**▪**Mobileye

**▪**Other

CCG, DCAI, and Intel Foundry qualify as reportable operating segments. When we enter into federal contracts, they are aligned to the sponsoring operating segment.

The accounting policies applied to our segments follow those applied to Intel as a whole. A summary of the basis for which we report our operating segment revenues and operating margin is as follows:

Intel Products: CCG and DCAI

**▪**Segment revenue: Consists of revenues from external customers. Our Intel Products operating segments represent most of Intel consolidated revenue and are derived from our principal products that incorporate various components and technologies, including a microprocessor and chipset, a stand-alone SoC, or a multichip package, which are based on Intel architecture.

**▪**Segment expenses: Consists of intersegment charges for product manufacturing and related services from Intel Foundry, external foundry and other manufacturing expenses, product development costs, allocated expenses as described below, and direct operating expenses.

Intel Foundry

**▪**Segment revenue: Consists substantially of intersegment product and services revenue for wafer fabrication, substrates and other related products, and services sold to Intel Products, Altera, and certain other Intel internal businesses. We recognize intersegment revenue based on the completion of performance obligations. Product revenue is recognized upon transfer of ownership, which is generally at the completion of wafer sorting. Backend service revenue is recognized upon the completion of assembly and test milestones, which approximates the recognition of revenue over the service period. Intersegment sales are recorded at prices that are intended to approximate market pricing. Intel Foundry also includes certain third-party foundry and assembly and test revenues from external customers that totaled $31 million in the first three months of 2025 and $13 million in the first three months of 2024.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsNotes to Financial Statements8

Table of Contents

**▪**Segment expenses: Consists of direct expenses for technology development, product manufacturing and services provided by Intel Foundry to internal and external customers, allocated expenses as described below, and direct operating expenses. Direct expenses for product manufacturing include excess capacity charges, if any.

All Other

Our "all other" category includes the results of operations from other non-reportable segments not otherwise presented, including our Altera and Mobileye businesses, our IMS business, start-up businesses that support our initiatives, and historical results of operations from divested businesses. The financial results of our all other category include intersegment product and services revenue and intersegment expenses.

We allocate operating expenses from our sales and marketing group to the Intel Products operating segments and allocate the significant majority of the operating expenses from our finance and administration groups to our operating segments.

We estimate that the substantial majority of our consolidated depreciation expense was incurred by Intel Foundry in the first three months of 2025 and 2024. Intel Foundry depreciation expense is substantially included in overhead cost pools and then combined with other costs, and subsequently absorbed into inventory as each product passes through the manufacturing process and is sold to Intel Products or other customers. As a result, it is impracticable to determine the total depreciation expense included as a component of each Intel Products operating segment's operating income (loss).

We do not allocate the following corporate operating expenses to our operating segments:

**▪**restructuring and other charges;

**▪**share-based compensation;

**▪**certain impairment charges; and

**▪**certain acquisition-related costs, including amortization and any impairment of acquisition-related intangibles and goodwill.

We do not allocate the following non-operating items to our operating segments:

**▪**gains and losses from equity investments;

**▪**interest and other income; and

**▪**income taxes.

Our Chief Executive Officer is our CODM. The CODM uses operating income (loss) to evaluate each segment's performance and allocate resources. This measure is utilized during our budgeting and forecasting process to assess profitability and enable decision making regarding strategic initiatives, capital investments, and personnel across all operating segments. Segment operating results regularly reviewed by our CODM also include cost of sales and operating expenses directly attributable to each segment. The financial measures regularly provided to and used by our CODM continue to evolve; currently, our CODM does not regularly review or receive discrete asset information by operating segment.

Intersegment eliminations: Intersegment sales and related gross margin on inventory recorded at the end of the period or sold through to third-party customers is eliminated for consolidation purposes. The Intel Products operating segments and Intel Foundry are meant to reflect separate fabless semiconductor and foundry companies, respectively. Thus, certain intersegment activity is captured within the intersegment eliminations upon consolidation and presented at the Intel consolidated level. This activity primarily relates to inventory reserves, which are determined and recorded based on our accounting policies for Intel as a whole but are only recorded by the Intel Products operating segments upon transfer of inventory from Intel Foundry. If a reserve is identified which relates to neither Intel Products operating segments nor Intel Foundry, the reserve is recognized as activity within the intersegment eliminations for Intel on a consolidated basis.

Reporting units and goodwill reallocation: As a result of modifying our segment reporting in the first quarter of 2025, we reallocated goodwill among our affected reporting units on a relative fair value basis. We performed a goodwill impairment assessment for each of our reporting units immediately before and after our business reorganization, concluding that goodwill was not impaired.

As a result of modifying our segment reporting in the first quarter of 2024, we reallocated goodwill among our affected reporting units on a relative fair value basis. We performed a quantitative goodwill impairment assessment for each of our reporting units immediately before and after our business reorganization. We concluded based on our pre-reorganization impairment test that goodwill was not impaired. As a result of our post-reorganization impairment test, we recognized a non-cash goodwill impairment loss of $222 million in the first three months of 2024 related to our new Intel Foundry reporting unit as the estimated fair value of the new reporting unit was lower than the assigned carrying value.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsNotes to Financial Statements9

Table of Contents

Net revenue, cost of sales, operating expenses, and operating income (loss) for each period were as follows:

Three Months Ended
(In Millions)Mar 29, 2025
Intel Products
CCGDCAITotal Intel ProductsIntel FoundryAll OtherCorporate UnallocatedIntersegment EliminationsTotal Consolidated
Revenue$7,629$4,126$11,755$4,667$943$—$(4,698)$12,667
Cost of sales3,9842,3596,3435,946396377(5,067)7,995
Operating expenses1,2841,1922,4761,0414448831294,973
Operating income (loss)$2,361$575$2,936$(2,320)$103$(1,260)$240$(301)
Three Months Ended
(In Millions)Mar 30, 2024
Intel Products
CCGDCAITotal Intel ProductsIntel FoundryAll OtherCorporate UnallocatedIntersegment EliminationsTotal Consolidated
Revenue$8,273$3,828$12,101$4,356$643$—$(4,376)$12,724
Cost of sales4,0041,7455,7495,617341701(4,901)7,507
Operating expenses1,4471,6663,1131,1804721,486356,286
Operating income (loss)$2,822$417$3,239$(2,441)$(170)$(2,187)$490$(1,069)
intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsNotes to Financial Statements10

Table of Contents

Corporate Unallocated Expenses

Corporate unallocated expenses include certain operating expenses not allocated to specific operating segments. The nature of these expenses may vary, but primarily consist of restructuring and other charges, share-based compensation, certain impairment charges, and certain acquisition-related costs.

Three Months Ended
(In Millions)Mar 29, 2025
Cost of SalesOperating ExpensesTotal
Acquisition-related costs$114$37$151
Share-based compensation175509684
Restructuring and other charges1—156156
Other88181269
Total corporate unallocated expenses$377$883$1,260
Three Months Ended
(In Millions)Mar 30, 2024
Cost of SalesOperating ExpensesTotal
Acquisition-related costs$224$41$265
Share-based compensation2988811,179
Restructuring and other charges1—348348
Other179216395
Total corporate unallocated expenses$701$1,486$2,187

1 See "Note 6: Restructuring and Other Charges" within Notes to Consolidated Condensed Financial Statements for further information.

Note 3 :Non-Controlling Interests
Non-Controlling Ownership %
Mar 29, 2025Mar 30, 2024
Ireland SCIP49%—%
Arizona SCIP49%49%
Mobileye12%12%
IMS32%32%
(In Millions)Ireland SCIPArizona SCIPMobileyeIMSTotal
Non-controlling interests as of Dec 28, 2024$61$3,888$1,672$141$5,762
Partner contributions—957——957
Partner distributions(58)———(58)
Changes in equity of non-controlling interest holders——62—62
Net income (loss) attributable to non-controlling interests39(92)(12)(1)(66)
Non-controlling interests as of Mar 29, 2025$42$4,753$1,722$140$6,657
(In Millions)Ireland SCIPArizona SCIPMobileyeIMSTotal
Non-controlling interests as of Dec 30, 2023$—$2,359$1,838$178$4,375
Partner contributions—423——423
Changes in equity of non-controlling interest holders——40141
Net income (loss) attributable to non-controlling interests—(22)(24)(10)(56)
Non-controlling interests as of Mar 30, 2024$—$2,760$1,854$169$4,783
intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsNotes to Financial Statements11

Table of Contents

Semiconductor Co-Investment Program

Ireland SCIP

We consolidate the results of an Irish limited liability company (Ireland SCIP), a VIE, into our Consolidated Condensed Financial Statements because we are the primary beneficiary. Generally, distributions will be received from Ireland SCIP based on each investor's respective ownership of Ireland SCIP, of which Intel's is 51%. Ireland SCIP has rights to factory output of an Intel owned wafer fabrication plant in Ireland (Fab 34) and rights to resell the factory output to us. We retain sole ownership of Fab 34 and we are engaged as the Fab 34 operator in exchange for variable payments from Ireland SCIP based on the related factory output. We are required to substantially complete construction of Fab 34 in accordance with contractual parameters and timelines or we will be required to pay delay-related liquidated damages to Apollo Global Management, Inc., the other investor, beginning in 2026, not to exceed $1.1 billion in total. Though we expect certain construction delays in the near term, we intend to complete construction of Fab 34. We will be required to purchase minimum quantities of the related factory output from Ireland SCIP, or we will be subject to certain volume-related damages payable to Ireland SCIP, beginning at the earlier of when construction is complete or the third quarter of 2027. As of March 29, 2025, other than cash and cash equivalents held by Ireland SCIP, substantially all of the remaining assets and liabilities of Ireland SCIP were eliminated in our Consolidated Condensed Financial Statements.

Arizona SCIP

We consolidate the results of an Arizona limited liability company (Arizona SCIP), a VIE, into our Consolidated Condensed Financial Statements because we are the primary beneficiary. Generally, contributions will be made to, and distributions will be received from Arizona SCIP based on our and Brookfield Asset Management's (Brookfield's) proportional ownership of Arizona SCIP; we will be the sole operator and main beneficiary of two new chip factories that are being constructed by Arizona SCIP; and we will be required to both operate Arizona SCIP at minimum production levels (measured in wafer starts per week) and limit excess inventory held on site or we will be subject to certain volume-related damages payable to Arizona SCIP. The assets held by Arizona SCIP, which are not available to us as they can be used only to settle obligations of the VIE and substantially consisted of property, plant, and equipment, were $14.3 billion as of March 29, 2025 ($11.5 billion as of December 28, 2024). The remaining assets and liabilities of Arizona SCIP were eliminated in our Consolidated Condensed Financial Statements.

Note 4 :Earnings (Loss) Per Share

We computed basic earnings (loss) per share of common stock based on the weighted average number of shares of common stock outstanding during the period. We computed diluted earnings (loss) per share of common stock based on the weighted average number of shares of common stock outstanding plus potentially dilutive shares of common stock outstanding during the period, if applicable.

Three Months Ended
(In Millions, Except Per Share Amounts)Mar 29, 2025Mar 30, 2024
Net income (loss)$(887)$(437)
Less: net income (loss) attributable to non-controlling interests(66)(56)
Net income (loss) attributable to Intel$(821)$(381)
Weighted average shares of common stock outstanding—basic4,3434,242
Weighted average shares of common stock outstanding—diluted4,3434,242
Earnings (loss) per share attributable to Intel—basic$(0.19)$(0.09)
Earnings (loss) per share attributable to Intel—diluted$(0.19)$(0.09)

Potentially dilutive shares of common stock from employee equity incentive plans are determined by applying the treasury stock method to the assumed exercise of outstanding stock options, the assumed vesting of outstanding RSUs, and the assumed issuance of common stock under the stock purchase plan. The potentially dilutive impact from the assumed issuance of common stock associated with a contractual conversion feature is determined by applying the if-converted method to the assumed exercise of the outstanding conversion feature.

Due to our net losses in the three months ended March 29, 2025 and March 30, 2024, the assumed exercise of outstanding stock options, the assumed vesting of outstanding RSUs, the assumed issuance of common stock under the stock purchase plan, and the assumed issuance of common stock associated with a contractual conversion feature, as applicable, had anti-dilutive effects on diluted loss per share and were excluded from the computations of diluted loss per share. At March 29, 2025 and March 30, 2024, securities that would have been anti-dilutive were insignificant.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsNotes to Financial Statements12

Table of Contents

Note 5 :Other Financial Statement Details

Accounts Receivable

We sell certain of our accounts receivable on a non-recourse basis to third-party financial institutions. We record these transactions as sales of receivables and present cash proceeds as cash provided by operating activities in the Consolidated Condensed Statements of Cash Flows. Accounts receivable sold under non-recourse factoring arrangements were $800 million during the first three months of 2025 ($500 million during the first three months of 2024). After the sale of our accounts receivable, we expect to collect payment from the customers and remit it to the third-party financial institution.

Inventories

(In Millions)Mar 29, 2025Dec 28, 2024
Raw materials$1,322$1,344
Work in process7,2407,432
Finished goods3,7193,422
Total inventories$12,281$12,198

Other Accrued Liabilities

Other accrued liabilities include deferred compensation of $2.7 billion as of March 29, 2025 ($3.3 billion as of December 28, 2024).

Interest and Other, Net

Three Months Ended
(In Millions)Mar 29, 2025Mar 30, 2024
Interest income$245$323
Interest expense(299)(258)
Other, net(119)80
Total interest and other, net$(173)$145

Interest expense is net of $312 million of interest capitalized in the first three months of 2025 ($363 million in the first three months of 2024).

Other, net includes a $94 million charge in the first three months of 2025 related to the sale of our NAND memory business (refer to "Note 9: Divestitures" within Notes to Consolidated Condensed Financial Statements).

Government Incentives

In the first three months of 2025, we recognized $778 million in grants under the CHIPS Act, including capital-related incentives which reduced gross property, plant and equipment by $690 million, and operating-related incentives which benefited operating income by $88 million, substantially all of which was recorded in cost of sales. Additionally, in the first three months of 2025 we recognized an advanced manufacturing investment tax credit of $298 million ($435 million in the first three months of 2024), which may be refunded to us in cash to the extent it exceeds our outstanding income tax liabilities.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsNotes to Financial Statements13

Table of Contents

Note 6 :Restructuring and Other Charges
Three Months Ended
(In Millions)Mar 29, 2025Mar 30, 2024
Employee severance and benefit arrangements$142$129
Litigation charges and other11—
Asset impairment charges3219
Total restructuring and other charges$156$348

In the third quarter of 2024, the 2024 Restructuring Plan was announced, subsequently approved and committed to by our management team, and initiated to implement cost-reduction measures, including reductions in employee headcount, other operating expenditures, and capital expenditures. Restructuring charges are primarily comprised of employee severance and benefit arrangements, non-cash charges related to asset impairments associated with exit activities, and charges relating to real estate exits and consolidations. These charges were included as "corporate unallocated expenses" within the restructuring and other category presented in "Note 2: Operating Segments" within Notes to Consolidated Condensed Financial Statements. We expect to recognize total charges of approximately $3.0 billion under the 2024 Restructuring Plan. The cumulative cost of the 2024 Restructuring Plan as of March 29, 2025, was $2.9 billion. Any changes to our estimates or timing will be reflected in our results of operations in future periods. We expect actions pursuant to the 2024 Restructuring Plan to be substantially complete by the fourth quarter of 2025, which is subject to change.

Employee severance and benefit arrangements includes a charge of $142 million in the first quarter of 2025 relating to the 2024 Restructuring Plan. Charges in the three months ended March 30, 2024 are primarily related to other actions taken to streamline operations and to reduce costs.

Restructuring activities related to employee severance and benefit arrangements under the 2024 Restructuring Plan were as follows for the first quarter of 2025:

(In Millions)
Accrued restructuring balance as of December 28, 2024$302
Accruals and adjustments140
Cash payments(277)
Accrued restructuring balance as of March 29, 2025$165

The accrued restructuring balance as of March 29, 2025 and December 28, 2024 was recorded as a current liability within accrued compensation and benefits on the Consolidated Condensed Balance Sheets.

Asset impairment charges includes a goodwill impairment loss of $222 million in the first quarter of 2024 related to our Intel Foundry reporting unit. Refer to "Note 2: Operating Segments" within Notes to Consolidated Condensed Financial Statements for further information.

Note 7 :Income Taxes
Three Months Ended
($ In Millions)Mar 29, 2025Mar 30, 2024
Income (loss) before taxes$(586)$(719)
Provision for (benefit from) taxes$301$(282)
Effective tax rate(51.4)%39.2%

In the three months ended March 29, 2025, our provision for income taxes was determined using our estimated annual effective tax rate, adjusted for discrete items, applied to our year-to-date measure of ordinary income (loss) before taxes, which reflects our jurisdictional mix of ordinary income and losses, including the valuation allowance applied to U.S. deferred tax balances.

In the three months ended March 30, 2024, our benefit from income taxes was determined using an actual annual effective tax rate, adjusted for discrete items, as we were unable to make a reliable estimate of our annual effective tax rate as a result of fluctuations in forecasted annual income and the effects of being taxed in multiple tax jurisdictions.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsNotes to Financial Statements14

Table of Contents

Note 8 :Investments

Short-term Investments

Short-term investments include marketable debt investments in corporate debt, government debt, and financial institution instruments, and are recorded within cash and cash equivalents and short-term investments on the Consolidated Condensed Balance Sheets*.* Government debt includes instruments such as non-US government bills and bonds and US agency securities. Financial institution instruments include instruments issued or managed by financial institutions in various forms, such as fixed- and floating-rate bonds, money market fund deposits, and time deposits. As of March 29, 2025 and December 28, 2024, substantially all time deposits were issued by institutions outside the US.

For certain of our marketable debt investments, we economically hedge market risks at inception with a related derivative instrument or the marketable debt investment itself is used to economically hedge currency exchange rate risk from remeasurement. These hedged investments are reported at fair value with gains or losses from the investments and the related derivative instruments recorded in interest and other, net. The fair value of our economically hedged marketable debt investments was $11.7 billion as of March 29, 2025 ($13.5 billion as of December 28, 2024). For hedged investments still held at the reporting date, we recorded net gains of $190 million in the first three months of 2025 ($307 million of net losses in the first three months of 2024).

Our remaining unhedged marketable debt investments are reported at fair value, with unrealized gains or losses, net of tax, recorded in accumulated other comprehensive income (loss) and realized gains or losses recorded in interest and other, net. The adjusted cost of our unhedged investments was $5.6 billion as of March 29, 2025 ($5.2 billion as of December 28, 2024), which approximated the fair value at these dates.

The fair value of marketable debt investments, by contractual maturity, as of March 29, 2025, was as follows:

(In Millions)Fair Value
Due in 1 year or less$4,146
Due in 1–2 years3,056
Due in 2–5 years6,063
Due after 5 years225
Instruments not due at a single maturity date13,848
Total$17,338

1 "Instruments not due at a single maturity date" is comprised of money market fund deposits, which are classified as either short-term investments or cash and cash equivalents.

Equity Investments

(In Millions)Mar 29, 2025Dec 28, 2024
Marketable equity investments1$541$848
Non-marketable equity investments4,4864,535
Total$5,027$5,383

1 Most of our marketable equity investments are subject to trading-volume or market-based restrictions, which limit the number of shares we may sell in a specified period of time, impacting our ability to liquidate these investments. Certain of the trading volume restrictions generally apply for as long as we own more than 1% of the outstanding shares. Market-based restrictions result from the rules of the respective exchange.

The components of gains (losses) on equity investments, net for each period were as follows:

Three Months Ended
(In Millions)Mar 29, 2025Mar 30, 2024
Unrealized gains (losses) on marketable equity investments$(292)$253
Unrealized gains (losses) on non-marketable equity investments1—24
Impairment charges(105)(69)
Unrealized gains (losses) on equity investments, net(397)208
Realized gains (losses) on sales of equity investments, net285(3)
Gains (losses) on equity investments, net$(112)$205

1 Unrealized gains (losses) on non-marketable investments includes observable price adjustments and our share of equity method investee gains (losses) and certain distributions.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsNotes to Financial Statements15

Table of Contents

Note 9 :Divestitures

NAND Memory Business

We sold our NAND memory technology and manufacturing business (the NAND OpCo Business) to SK hynix Inc. (SK hynix) which we deconsolidated upon closing the first phase of the transaction on December 29, 2021. On March 27, 2025, we closed the second phase of the transaction, collected the outstanding receivable, and recorded proceeds of $1.9 billion within cash and cash equivalents, net of certain adjustments.

In connection with the second closing, we entered into a final release and settlement agreement with SK hynix primarily related to certain penalties associated with the manufacturing and sale agreement between us and SK hynix, recognizing a net charge of $94 million within Interest and Other, net for the amount paid to SK hynix during the first quarter of 2025.

Altera FPGA Business

On April 14, 2025, we signed a transaction agreement with SLP VII Gryphon Aggregator, L.P., an affiliate of Silver Lake Partners (SLP), to sell 51% of all issued and outstanding common stock of Altera, a wholly owned subsidiary. The transaction is expected to close in the second half of 2025, subject to regulatory approvals and other customary closing conditions, and is expected to result in the receipt of net cash proceeds of $4.4 billion, after adjusting for certain amounts that we bear responsibility for pursuant to the transaction agreement, including the separation costs described below. Pursuant to the transaction agreement, $1.0 billion of the purchase price will be deferred and payable in two equal $500 million installments no later than December 31, 2026 and December 31, 2027. Receipt of the deferred consideration is not subject to any contingencies. Upon closing the transaction, we will retain a 49% minority investment in the business.

Contemporaneously with the execution of the transaction agreement, we entered into a separation agreement with SLP that sets forth the terms for the completion of the separation of Altera from Intel to operate on a standalone basis, including our agreement to fund separation costs and expenses up to an aggregate amount of $277 million. In connection with the transaction, we anticipate entering into certain ancillary agreements that govern, among other things, intellectual property rights, employee matters, government contracting, and a wafer manufacturing and sale agreement pursuant to which we will provide semiconductor wafer manufacturing services to Altera.

Note 10 :Borrowings

In the first quarter of 2025, we amended our 364-day $8.0 billion credit facility agreement to $5.0 billion, and the maturity date was extended by one year to January 2026. Neither of our revolving credit facilities had borrowings outstanding as of March 29, 2025 or December 28, 2024.

We have an ongoing authorization from our Board of Directors to borrow up to $10.0 billion under our commercial paper program. We had $1.5 billion of 4.52% - 4.61% commercial paper outstanding as of March 29, 2025 (no commercial paper outstanding as December 28, 2024). Borrowings under the commercial paper program are unsecured general obligations.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsNotes to Financial Statements16

Table of Contents

Note 11 :Fair Value

Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis

Mar 29, 2025Dec 28, 2024
Fair Value Measured and Recorded at Reporting Date UsingFair Value Measured and Recorded at Reporting Date Using
(In Millions)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets
Cash equivalents:
Corporate debt$—$306$—$306$—$—$—$—
Financial institution instruments¹3,6871,244—4,9314,121743—4,864
Reverse repurchase agreements—2,599—2,599—2,654—2,654
Short-term investments:
Corporate debt—6,101—6,101—5,365—5,365
Financial institution instruments¹1603,486—3,6461953,356—3,551
Government debt²442,310—2,354334,864—4,897
Other current assets:
Derivative assets2471—473348733—1,081
Marketable equity investments541——541848——848
Other long-term assets:
Derivative assets—3—3—1—1
Total assets measured and recorded at fair value$4,434$16,520$—$20,954$5,545$17,716$—$23,261
Liabilities
Other accrued liabilities:
Derivative liabilities$88$298$129$515$—$562$134$696
Other long-term liabilities:
Derivative liabilities³—2917551,046—4167551,171
Total liabilities measured and recorded at fair value$88$589$884$1,561$—$978$889$1,867

1**Level 1 investments consist of money market funds. Level 2 investments consist primarily of time deposits, notes, and bonds issued by financial institutions.

2**Level 1 investments consist primarily of US Treasury securities. Level 2 investments consist primarily of non-US government debt.

3**Level 3 derivative liabilities include liquidated damage provisions related to our Ireland SCIP arrangement.

Assets Measured and Recorded at Fair Value on a Non-Recurring Basis

Our non-marketable equity investments, equity method investments, and certain non-financial assets—such as intangible assets, goodwill, and property, plant, and equipment—are recorded at fair value only if an impairment or observable price adjustment is recognized in the current period. If an observable price adjustment or impairment is recognized on our non-marketable equity investments during the period, we classify these assets as Level 3. Similarly, impairments recognized on our goodwill, intangible assets, and property, plant, and equipment are categorized as Level 3 within the fair value hierarchy as we utilize unobservable inputs such as prospective financial information, market segment growth rates, and discount rates in the fair value measurement process.

Financial Instruments Not Recorded at Fair Value on a Recurring Basis

Financial instruments not recorded at fair value on a recurring basis include non-marketable equity investments and equity method investments that have not been remeasured or impaired in the current period, grants receivable, and issued debt.

We classify the fair value of grants receivable as Level 2. The estimated fair value of these financial assets approximates their carrying value. The aggregate carrying value of grants receivable as of March 29, 2025, was $757 million (the aggregate carrying value of grants receivable as of December 28, 2024, was $1.7 billion).

We classify the fair value of issued debt (excluding any commercial paper) as Level 2. The fair value of these instruments was $42.7 billion as of March 29, 2025 ($43.5 billion as of December 28, 2024).

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsNotes to Financial Statements17

Table of Contents

Note 12 :Derivative Financial Instruments

Volume of Derivative Activity

Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows:

(In Millions)Mar 29, 2025Dec 28, 2024
Foreign currency contracts$20,303$25,472
Interest rate contracts18,59417,899
Other2,4672,593
Total$41,364$45,964

The total notional amount of outstanding pay-variable, receive-fixed interest rate swaps was $12.0 billion as of March 29, 2025 and December 28, 2024.

Fair Value of Derivative Instruments in the Consolidated Condensed Balance Sheets

Mar 29, 2025Dec 28, 2024
(In Millions)Assets****1Liabilities****2Assets****1Liabilities****2
Derivatives designated as hedging instruments:
Foreign currency contracts3$102$100$40$405
Interest rate contracts—441—582
Total derivatives designated as hedging instruments$102$541$40$987
Derivatives not designated as hedging instruments:
Foreign currency contracts3$235$122$510$100
Interest rate contracts1375518425
Equity contracts288348—
Other4—755—755
Total derivatives not designated as hedging instruments$374$1,020$1,042$880
Total derivatives$476$1,561$1,082$1,867

1**Derivative assets are recorded as other assets, current and long-term.

2**Derivative liabilities are recorded as other liabilities, current and long-term.

3**A substantial majority of these instruments mature within 12 months.

4**Embedded derivative related to our Ireland SCIP arrangement.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsNotes to Financial Statements18

Table of Contents

Amounts Offset in the Consolidated Condensed Balance Sheets

Agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows:

Mar 29, 2025
Gross Amounts Not Offset in the Balance Sheet
(In Millions)Gross Amounts RecognizedGross Amounts Offset in the Balance SheetNet Amounts Presented in the Balance SheetFinancial InstrumentsCash and Non-Cash Collateral Received or PledgedNet Amount
Assets:
Derivative assets subject to master netting arrangements$349$—$349$(214)$(135)$—
Reverse repurchase agreements2,599—2,599—(2,599)—
Total assets$2,948$—$2,948$(214)$(2,734)$—
Liabilities:
Derivative liabilities subject to master netting arrangements$777$—$777$(214)$(504)$59
Total liabilities$777$—$777$(214)$(504)$59
Dec 28, 2024
Gross Amounts Not Offset in the Balance Sheet
(In Millions)Gross Amounts RecognizedGross Amounts Offset in the Balance SheetNet Amounts Presented in the Balance SheetFinancial InstrumentsCash and Non-Cash Collateral Received or PledgedNet Amount
Assets:
Derivative assets subject to master netting arrangements$948$—$948$(269)$(679)$—
Reverse repurchase agreements2,654—2,654—(2,654)—
Total assets$3,602$—$3,602$(269)$(3,333)$—
Liabilities:
Derivative liabilities subject to master netting arrangements$1,084$—$1,084$(269)$(745)$70
Total liabilities$1,084$—$1,084$(269)$(745)$70

We obtain and secure available collateral from counterparties against obligations, including securities lending transactions and reverse repurchase agreements, when we deem it appropriate.

Derivatives in Cash Flow Hedging Relationships

The before-tax net gains or losses attributed to the effective portion of cash flow hedges recognized in other comprehensive income (loss) were $180 million net gains in the first three months of 2025 ($431 million net losses in the first three months of 2024).

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsNotes to Financial Statements19

Table of Contents

Derivatives in Fair Value Hedging Relationships

The effects of derivative instruments designated as fair value hedges, recognized in interest and other, net for each period were as follows:

Gains (Losses) on Derivatives Recognized in Consolidated Condensed Statements of Operations
Three Months Ended
(In Millions)Mar 29, 2025Mar 30, 2024
Interest rate contracts$141$(144)
Hedged items(141)144
Total$—$—

The amounts recorded on the Consolidated Condensed Balance Sheets related to cumulative basis adjustments for fair value hedges for each period were as follows:

Line Item in the Consolidated Condensed Balance Sheets in Which the Hedged Item is IncludedCarrying Amount of the Hedged Item Assets/(Liabilities)Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount Assets/(Liabilities)
(In Millions)Mar 29, 2025Dec 28, 2024Mar 29, 2025Dec 28, 2024
Short-term debt$(2,229)$(2,214)$21$36
Long-term debt(9,327)(9,201)420546
Total$(11,556)$(11,415)$441$582

Derivatives Not Designated as Hedging Instruments

The effects of derivative instruments not designated as hedging instruments on the Consolidated Condensed Statements of Operations for each period were as follows:

Three Months Ended
(In Millions)Location of Gains (Losses) Recognized in Income on DerivativesMar 29, 2025Mar 30, 2024
Foreign currency contractsInterest and other, net$(85)$346
Interest rate contractsInterest and other, net(57)117
OtherVarious(157)137
Total$(299)$600
Note 13 :Contingencies

Legal Proceedings

We are regularly party to various ongoing claims, litigation, and other proceedings, including those noted in this section. As of March 29, 2025, we have accrued a charge of $1.0 billion related to litigation involving VLSI and a charge of $401 million related to an EC-imposed fine, both as described below. Excluding the VLSI claims described below, management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends; however, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings, excessive verdicts, or other events could occur. Unfavorable resolutions could include substantial monetary damages, fines, or penalties. Certain of these outstanding matters include speculative, substantial, or indeterminate monetary awards. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. An unfavorable outcome may result in a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees, and customers, and any such settlement could include substantial payments. Unless specifically described below, we have not concluded that settlement of any of the legal proceedings noted in this section is appropriate at this time.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsNotes to Financial Statements20

Table of Contents

European Commission Competition Matter

In 2009, the EC found that we had used unfair business practices to persuade customers to buy microprocessors in violation of Article 82 of the EC Treaty (later renumbered Article 102) and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 by offering alleged “conditional rebates and payments” that required customers to purchase all or most of their x86 microprocessors from us and by making alleged “payments to prevent sales of specific rival products.” The EC ordered us to end the alleged infringement referred to in its decision and imposed a €1.1 billion fine, which we paid in the third quarter of 2009.

We appealed the EC decision to the European Court of Justice in 2014, after the General Court (then called the Court of First Instance) rejected our appeal of the EC decision in its entirety. In September 2017, the Court of Justice sent the case back to the General Court to examine whether the rebates at issue were capable of restricting competition. In January 2022, the General Court annulled the EC's 2009 findings against us regarding rebates, as well as the €1.1 billion fine imposed on Intel, which was returned to us in February 2022. The General Court's January 2022 decision did not annul the EC's 2009 finding that we made payments to prevent sales of specific rival products.

In April 2022, the EC appealed the General Court's findings regarding rebates to the Court of Justice. In October 2024, the Court of Justice dismissed the EC's appeal, upholding the judgment of the General Court.

In September 2023, the EC imposed a €376 million ($401 million) fine against us based on its 2009 finding that we made payments to prevent sales of specific rival products. We have appealed the EC's decision. We have accrued a charge for the fine and are unable to make a reasonable estimate of the potential loss or range of losses in excess of this amount given the procedural posture and the nature of these proceedings.

Litigation Related to Security Vulnerabilities

In June 2017, a Google research team notified Intel and other companies that it had identified security vulnerabilities, the first variants of which are now commonly referred to as “Spectre” and “Meltdown,” that affect many types of microprocessors, including our products. As is standard when findings like these are presented, we worked together with other companies in the industry to verify the research and develop and validate software and firmware updates for impacted technologies. In January 2018, information on the security vulnerabilities was publicly reported, before software and firmware updates to address the vulnerabilities were made widely available.

Consumer class action lawsuits against us were pending in the US and Canada. The plaintiffs, who purport to represent various classes of purchasers of our products, generally claim to have been harmed by our actions and/or omissions in connection with Spectre, Meltdown, and other variants of this class of security vulnerabilities that have been identified since 2018, and assert a variety of common law and statutory claims seeking monetary damages and equitable relief. In the US, class action suits filed in various jurisdictions between 2018 and 2021 were consolidated for all pretrial proceedings in the US District Court for the District of Oregon, which entered final judgment in favor of Intel in July 2022 based on plaintiffs' failure to plead a viable claim. The Ninth Circuit Court of Appeals affirmed the district court's judgment in November 2023, ending the litigation. In November 2023, new plaintiffs filed a consumer class action complaint in the US District Court for the Northern District of California with respect to a further vulnerability variant disclosed in August 2023 and commonly referred to as “Downfall.” In August 2024, the district court dismissed plaintiffs' complaint for failure to plead a viable claim. Plaintiffs filed an amended complaint in September 2024, which we moved to dismiss in October 2024. In Canada, an initial status conference has not yet been scheduled in one case relating to Spectre and Meltdown pending in the Superior Court of Justice of Ontario, and a stay of a second case pending in the Superior Court of Justice of Quebec is in effect. Additional lawsuits and claims may be asserted seeking monetary damages or other related relief. Given the procedural posture and the nature of these cases, including that the pending proceedings are in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class or classes being certified or the ultimate size of any class or classes if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from these matters.

Litigation Related to Segment Reporting and Internal Foundry Model

A securities class action lawsuit was filed in the US District Court for the Northern District of California in May 2024 against us and certain officers following the modification of our segment reporting in the first quarter of 2024 to align to our new internal foundry operating model. In August 2024, the court ordered the case consolidated with a second, similar lawsuit, and in October 2024 plaintiffs filed an amended consolidated complaint generally alleging that defendants violated the federal securities laws by making false or misleading statements about the growth and prospects of the foundry business and seeking monetary damages on behalf of all persons and entities that purchased or otherwise acquired our common stock or purchased call options or sold put options on our common stock from January 25, 2024 through August 1, 2024. In early March 2025, the court granted defendants' motion to dismiss the amended consolidated complaint. The court granted plaintiffs leave to amend, and in late March 2025 plaintiffs filed a second amended complaint. In April 2025 defendants filed a motion to dismiss the second amended complaint. Given the procedural posture and the nature of the case, including that it is in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class being certified or the ultimate size of any class if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from the matter.

Stockholder derivative lawsuits have been filed in Delaware state and federal courts alleging that our directors and certain officers breached their fiduciary duties and violated the federal securities laws by making or allowing the statements that are challenged in the securities class action lawsuit. The plaintiffs in the derivative lawsuits seek to recover damages from the defendants on behalf of Intel. By stipulation of the parties, the Delaware state and federal courts have ordered the cases before them stayed pending certain developments in the securities class action lawsuit.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsNotes to Financial Statements21

Table of Contents

Litigation Related to Patent and IP Claims

We have had IP infringement lawsuits filed against us, including but not limited to those discussed below. Most involve claims that certain of our products, services, and technologies infringe others' IP rights. Adverse results in these lawsuits may include awards of substantial fines and penalties, costly royalty or licensing agreements, or orders preventing us from offering certain features, functionalities, products, or services. As a result, we may have to change our business practices, and develop non-infringing products or technologies, which could result in a loss of revenue for us and otherwise harm our business. In addition, certain agreements with our customers require us to indemnify them against certain IP infringement claims, which can increase our costs as a result of defending such claims, and may require that we pay significant damages, accept product returns, or supply our customers with non-infringing products if there were an adverse ruling in any such claims. In addition, our customers and partners may discontinue the use of our products, services, and technologies, as a result of injunctions or otherwise, which could result in loss of revenue and adversely affect our business.

VLSI Technology LLC v. Intel

In October 2017, VLSI Technology LLC (VLSI) filed a complaint against us in the US District Court for the Northern District of California alleging that various Intel FPGA and processor products infringe eight patents VLSI acquired from NXP Semiconductors, N.V. (NXP). VLSI sought damages, attorneys' fees, costs, and interest. Intel prevailed on all eight patents and the court entered final judgment in April 2024. VLSI appealed the Court's judgment of non-infringement as to one of the eight patents. In April 2019, VLSI filed three infringement suits against us in the US District Court for the Western District of Texas accusing various of our processors of infringement of eight additional patents it had acquired from NXP:

▪The first Texas case went to trial in February 2021, and the jury awarded VLSI $1.5 billion for literal infringement of one patent and $675 million for infringement of another patent under the doctrine of equivalents. In April 2022, the court entered final judgment, awarding VLSI $2.2 billion in damages and approximately $162 million in pre-judgment and post-judgment interest. We appealed the judgment to the Federal Circuit Court of Appeals, including the court's rejection of Intel's claim to have a license from Fortress Investment Group's acquisition of Finjan. The Federal Circuit Court heard oral argument in October 2023. In December 2023, the Federal Circuit reversed the finding of infringement as to the patent for which VLSI was awarded $675 million. The Federal Circuit affirmed the finding of infringement as to the patent for which VLSI had been awarded $1.5 billion, but vacated the damages award and sent the case back to the trial court for further damages proceedings on that patent. The Federal Circuit also ruled that Intel can advance the defense that it is licensed to VLSI's patents. In December 2021 and January 2022 the Patent Trial and Appeal Board (PTAB) instituted Inter Partes Reviews (IPR) on the claims found to have been infringed in the first Texas case, and in May and June 2023 found all of those claims unpatentable; VLSI has appealed the PTAB's decisions. In April 2024, Intel moved to add the defense that it is licensed to VLSI's patents. The motion remains pending.

▪The second Texas case went to trial in April 2021, and the jury found that we do not infringe the asserted patents. VLSI had sought approximately $3.0 billion for alleged infringement, plus enhanced damages for willful infringement. In September 2024, the court denied VLSI's motion for a new trial. Other post-trial motions remain pending, and the court has not yet entered final judgment.

▪The third Texas case went to trial in November 2022, with VLSI asserting one remaining patent. The jury found the patent valid and infringed, and awarded VLSI approximately $949 million in damages, plus interest and a running royalty. The court has not yet entered final judgment. In February 2023, we filed motions for a new trial and for judgment as a matter of law notwithstanding the verdict on various grounds. Further appeals are possible. In April 2024, Intel moved to add the defense that it is licensed to VLSI's patents, and the court granted Intel's motion that same month. Trial on the license defense has been set for May 2025.

In May 2019, VLSI filed a case in Shenzhen Intermediate People's Court against Intel, Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. VLSI asserted one patent against certain Intel Core processors. Defendants filed an invalidation petition in October 2019 with the China National Intellectual Property Administration (CNIPA) which held a hearing in September 2021. The Shenzhen court held trial proceedings in July 2021 and September 2023. VLSI sought an injunction as well as RMB 1.3 million in costs and expenses, but no damages. In September 2023, the CNIPA invalidated every claim of the asserted patent. In November 2023, the trial court dismissed VLSI's case.

In May 2019, VLSI filed a case in Shanghai Intellectual Property Court against Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. asserting one patent against certain Intel core processors. The court held a trial hearing in December 2020, where VLSI requested expenses (RMB 300 thousand) and an injunction. In December 2022, we filed a petition to invalidate the patent at issue. In February 2024, the patent was found not invalid, and Intel appealed the decision in May 2024. The appeal remains pending. The court held a second trial hearing in May 2022, and in October 2023, issued a decision finding no infringement and dismissing all claims. In November 2023, VLSI appealed the finding of non-infringement to the Supreme People's Court. The Supreme People's Court held an evidentiary hearing in October 2024, and a trial in November 2024.

In July 2024, Intel filed suit against VLSI in US District Court for the District of Delaware requesting the court find Intel is licensed to VLSI's patents. In September 2024, VLSI filed motions requesting that Intel's complaint be dismissed, transferred, or stayed. In December 2024, the Delaware court stayed the case and deferred the pending motions until May 31, 2025.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsNotes to Financial Statements22

Table of Contents

As of March 29, 2025, we have accrued a charge of approximately $1.0 billion related to the VLSI litigation. We are unable to make a reasonable estimate of losses in excess of recorded amounts.

Eire Og Innovations v IBM et. al.

Between April and present, Eire Og Innovations Ltd. has filed eleven separate complaints in the Eastern and Western Districts of Texas against Intel and AMD customers alleging that various products with Intel and AMD CPUs infringe numerous patents. Eire Og seeks compensatory damages, future royalties, attorneys’ fees, costs, and interest. Intel is indemnifying Acer, Cisco, Dell, HPE, HPI, IBM, Lenovo, and Oracle in connection with Intel CPUs accused of infringing four patents. Cisco and IBM filed their answers in June 2024. In these cases, a Markman hearing is scheduled for June 2025, and trial is scheduled for December 2025. Dell, HPI and Oracle filed their answers in June, August and September 2024, respectively. The Markman hearing in those matters is currently scheduled for May 2025, and trial is expected to be set for May 2026. Lenovo filed a motion to dismiss for lack of jurisdiction in July 2024, which was denied, and it subsequently filed an answer in October 2024. HPE and Acer filed their answers in July and September 2024, respectively. The Markman hearing for the Lenovo, HPE and Acer matters is scheduled for September 2025, and trial in those matters is scheduled for March 2026. Given the procedural posture and the nature of these cases, including that the pending proceedings are in the early stages, that alleged damages have not been specified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from these matters.

intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsNotes to Financial Statements23

Table of Contents

Key Terms

We use terms throughout our document that are specific to Intel or that are abbreviations that may not be commonly known or used. Below is a list of these terms used in our document.

TermDefinition
2024 Restructuring PlanCost and capital reduction initiatives approved by management, the board of directors or the Audit & Finance Committee of the board of directors designed to adjust spending to current business trends and achieve objectives announced in Q3 2024 with respect to reducing operating expenses, reducing capital expenditures and reducing cost of sales while enabling Intel's new operating model and continuing to fund investments in Intel's core strategy.
5GThe fifth-generation mobile network, which brings dramatic improvements in network speeds and latency, and which we view as a transformative technology and opportunity for many industries
AIArtificial intelligence
ApolloApollo Global Management, Inc.
ASPAverage selling price
Back end servicesIncludes assembly, test and packaging services
BrookfieldBrookfield Asset Management
CCGClient Computing Group operating segment
CHIPS ActCreating Helpful Incentives to Produce Semiconductors for America Act
CODMChief operating decision maker
CPUProcessor or central processing unit
DCAIData Center and Artificial Intelligence operating segment
ECEuropean Commission
EPSEarnings per share
2024 Form 10-KAnnual Report on Form 10-K for the year ended December 28, 2024
FPGAField-programmable gate array
IMSIMS Nanofabrication GmbH, a business within Intel Foundry that develops and produces electron-beam systems for the semiconductor industry
IPIntellectual property
MD&AManagement's Discussion and Analysis
MG&AMarketing, general, and administrative
NANDNAND flash memory
NEXNetworking and Edge operating segment
R&DResearch and development
RSURestricted stock unit
SCIPSemiconductor Co-Investment Program
SECUS Securities and Exchange Commission
Smart CapitalOur Smart Capital approach accelerates progress on our strategy. This approach is designed to enable us to adjust quickly to opportunities in the market, while managing our margin structure and capital spending. The elements of Smart Capital include capacity investments, government incentives, customer commitments, continued use of external foundries.
SoCSystem on a chip, which integrates most of the components of a computer or other electronic system into a single silicon chip. We offer a range of SoC products in CCG, DCAI, and NEX. Our DCAI and NEX businesses offer SoCs across many market segments for a variety of applications, including products targeted for 5G base stations and network infrastructure
USUnited States
US GAAPUS Generally Accepted Accounting Principles
VIEVariable interest entity
intel-logo-ub-RGB_PL-Energy_PL-Energy (002)_upd.jpgFinancial StatementsNotes to Financial Statements24

Previous: Cover and table of contents · Next: Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations